Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in Am J Alzheimers Dis Other Demen

Retrieve available abstracts of 52 articles:
HTML format



Single Articles


    January 2022
  1. RAVIPATI K, Chen Y, Manns JR
    Reassessing Diabetes and APOE Genotype as Potential Interacting Risk Factors for Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2022;37:15333175211070912.
    PubMed     Abstract available


  2. SCHAEFER SY, Duff K, Hooyman A, Hoffman JM, et al
    Improving Prediction of Amyloid Deposition in Mild Cognitive Impairment With a Timed Motor Task.
    Am J Alzheimers Dis Other Demen. 2022;37:15333175211048262.
    PubMed     Abstract available


  3. CHAUDHARY S, Zhornitsky S, Chao HH, van Dyck CH, et al
    Emotion Processing Dysfunction in Alzheimer's Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology.
    Am J Alzheimers Dis Other Demen. 2022;37:15333175221082834.
    PubMed     Abstract available


  4. ZHANG X, Zou M, Wu Y, Jiang D, et al
    Regulation of the Late Onset alzheimer's Disease Associated HLA-DQA1/DRB1 Expression.
    Am J Alzheimers Dis Other Demen. 2022;37:15333175221085066.
    PubMed     Abstract available


  5. LU J, Liu L, Chen J, Zhi J, et al
    The Involvement of lncRNA HOTAIR/miR-130a-3p Axis in the Regulation of Voluntary Exercise on Cognition and Inflammation of Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2022;37:15333175221091424.
    PubMed     Abstract available


  6. MONTESINOS R, Parodi JF, Diaz MM, Herrera-Perez E, et al
    Validation of Picture Free and Cued Selective Reminding Test for Illiteracy in Lima, Peru.
    Am J Alzheimers Dis Other Demen. 2022;37:15333175221094396.
    PubMed     Abstract available


  7. CUSTODIO N, Montesinos R, Chambergo-Michilot D, Herrera-Perez E, et al
    A Functional Assessment Tool to Distinguish Controls From Alzheimer's Disease in Lima, Peru.
    Am J Alzheimers Dis Other Demen. 2022;37:15333175221104354.
    PubMed     Abstract available


  8. XU X, Ruan X, Ju R, Wang Z, et al
    Progesterone Receptor Membrane Component-1 May Promote Survival of Human Brain Microvascular Endothelial Cells in Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2022;37:15333175221109749.
    PubMed     Abstract available


    January 2021
  9. CHANG CW, Juan YS, Yang YH, Lee HY, et al
    The Relationship Between Lower Urinary Tract Symptoms and Severity of Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2021;36:1533317521992657.
    PubMed     Abstract available


  10. KHAN A, Das S, Sergi C
    Therapeutic Potential of Neu1 in Alzheimer's Disease Via the Immune System.
    Am J Alzheimers Dis Other Demen. 2021;36:1533317521996147.
    PubMed     Abstract available


  11. ABBATEMARCO JR, Jones SE, Larvie M, Bekris LM, et al
    Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker Phenotype.
    Am J Alzheimers Dis Other Demen. 2021;36:1533317520981225.
    PubMed     Abstract available


  12. LU L, Dai WZ, Zhu XC, Ma T, et al
    Analysis of Serum miRNAs in Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211021712.
    PubMed     Abstract available


  13. WANG Y, Shi M, Hong Z, Kang J, et al
    MiR-130a-3p Has Protective Effects in Alzheimer's Disease via Targeting DAPK1.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211020572.
    PubMed     Abstract available


  14. NA H, Tian H, Zhang Z, Li Q, et al
    Oral Amylin Treatment Reduces the Pathological Cascade of Alzheimer's Disease in a Mouse Model.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211012867.
    PubMed     Abstract available


  15. LUQUE-TIRADO A, Rodrigo-Herrero S, Sanchez-Arjona MB, Franco-Macias E, et al
    Preliminary Validation of the Triana Test: A New Story Recall Test Based on Emotional Material.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211025911.
    PubMed     Abstract available


  16. HE Y, Qiang Y
    Mechanism of Autonomic Exercise Improving Cognitive Function of Alzheimer's Disease by Regulating lncRNA SNHG14.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211027681.
    PubMed     Abstract available


  17. CUSTODIO N, Castro-Suarez S, Montesinos R, Failoc-Rojas VE, et al
    Neuropsychiatric Symptoms in Patients With Alzheimer's Disease During SARS-COV-2 Pandemic in Peru.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211039089.
    PubMed     Abstract available


  18. HENDRIKS I, Demetrio R, Meiland FJM, Chattat R, et al
    Value of Personalized Dementia-Specific Quality of Life Scales: An Explorative Study in 3 European Countries.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211033721.
    PubMed     Abstract available


  19. NAKAMURA T
    The Impact of Diet Type on Weight Loss in Patients with Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211044883.
    PubMed     Abstract available


  20. BAI R, Dong W
    Trends in Mortality Rates for Alzheimer's Disease and Other Dementias Over 30 Years in China.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211044884.
    PubMed     Abstract available


  21. CHENG Y, Sun M, Wang F, Geng X, et al
    Identification of Hub Genes Related to Alzheimer's Disease and Major Depressive Disorder.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211046123.
    PubMed     Abstract available


  22. MEYSAMI S, Raji CA, Merrill DA, Porter VR, et al
    Quantitative MRI Differences Between Early versus Late Onset Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211055325.
    PubMed     Abstract available


  23. GAN J, Liu S, Chen Z, Wang XD, et al
    Effect of Multiple Medicines on Dementia Initial Treatment: Experience and Thinking.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211053134.
    PubMed     Abstract available


    January 2020
  24. TENTORIO T, Dentali S, Moioli C, Zuffi M, et al
    Anxiety and Depression Are Not Related to Increasing Levels of Burden and Stress in Caregivers of Patients With Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317519899544.
    PubMed     Abstract available


  25. WAKE T, Tabuchi H, Funaki K, Ito D, et al
    Disclosure of Amyloid Status for Risk of Alzheimer Disease to Cognitively Normal Research Participants With Subjective Cognitive Decline: A Longitudinal Study.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520904551.
    PubMed     Abstract available


  26. DE SOUSA OV, Mendes J, Amaral TF
    Nutritional and Functional Indicators and Their Association With Mortality Among Older Adults With Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520907168.
    PubMed     Abstract available


  27. AKIMOTO H, Negishi A, Oshima S, Wakiyama H, et al
    Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317519899546.
    PubMed     Abstract available


  28. SOUZA VC, Morais GS Jr, Henriques AD, Machado-Silva W, et al
    Whole-Blood Levels of MicroRNA-9 Are Decreased in Patients With Late-Onset Alzheimer Disease.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520911573.
    PubMed     Abstract available


  29. BRAMBOECK V, Moeller K, Marksteiner J, Kaufmann L, et al
    Loneliness and Burden Perceived by Family Caregivers of Patients With Alzheimer Disease.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520917788.
    PubMed     Abstract available


  30. ISELLA V, Rosazza C, Gazzotti M, Sala J, et al
    A Metabolic Imaging Study of Lexical and Phonological Naming Errors in Alzheimer Disease.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520922390.
    PubMed     Abstract available


  31. MAYELLE A, El Haj M, Antoine P
    "What" and "How": A New Perspective for Understanding Unawareness in Alzheimer's Disease Through a Combination of Two Perspectives.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520925333.
    PubMed     Abstract available


  32. LI C, Chen YH, Zhang K
    Neuroprotective Properties and Therapeutic Potential of Bone Marrow-Derived Microglia in Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520927169.
    PubMed     Abstract available


  33. BENOIT JS, Chan W, Piller L, Doody R, et al
    Longitudinal Sensitivity of Alzheimer's Disease Severity Staging.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520918719.
    PubMed     Abstract available


  34. JERVIS BW, Bigan C, Besleaga M
    New-Onset Alzheimer's Disease and Normal Subjects 100% Separated Statistically by P300 and ICA.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520935675.
    PubMed     Abstract available


  35. ALTINTAS E, Moustafa AA, Gallouj K, Haj ME, et al
    The Swinging Self: The Costs of Shifting Between Self-Images in Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520905401.
    PubMed     Abstract available


  36. ZHOU C, Wu Q, Wang Z, Wang Q, et al
    The Effect of Hormone Replacement Therapy on Cognitive Function in Female Patients With Alzheimer's Disease: A Meta-Analysis.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520938585.
    PubMed     Abstract available


  37. MCKENNA SP, Rouse M, Heaney A, Hagell P, et al
    International Development of the Alzheimer's Patient Partners Life Impact Questionnaire (APPLIQue).
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520951690.
    PubMed     Abstract available


  38. GUPTA S, Nair A, Jhawat V, Mustaq N, et al
    Unwinding Complexities of Diabetic Alzheimer by Potent Novel Molecules.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520937542.
    PubMed     Abstract available


  39. QUINONES AR, Kaye J, Allore HG, Botoseneanu A, et al
    An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities in Alzheimer's Disease and Related Dementia.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520960874.
    PubMed     Abstract available


  40. MASKERY M, Goulding EM, Gengler S, Melchiorsen JU, et al
    The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520953041.
    PubMed     Abstract available


  41. WEEKES BSH
    Aphasia in Alzheimer's Disease and Other Dementias (ADOD): Evidence From Chinese.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520949708.
    PubMed     Abstract available


  42. LUZZATTI C, Mauri I, Castiglioni S, Zuffi M, et al
    Evaluating Semantic Knowledge Through a Semantic Association Task in Individuals With Dementia.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520917294.
    PubMed     Abstract available


  43. SNYDER SA, Vitaliano PP
    Caregiver Psychological Distress: Longitudinal Relationships With Physical Activity and Diet.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520904554.
    PubMed     Abstract available


  44. TONGA JB, Eilertsen DE, Solem IKL, Arnevik EA, et al
    Effect of Self-Efficacy on Quality of Life in People With Mild Cognitive Impairment and Mild Dementia: The Mediating Roles of Depression and Anxiety.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317519885264.
    PubMed     Abstract available


  45. NAHARCI MI, Celebi F, Oguz EO, Yilmaz O, et al
    The Turkish Version of the Telephone Cognitive Screen for Detecting Cognitive Impairment in Older Adults.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317519889810.
    PubMed     Abstract available


  46. LI X, Zhan Z, Zhang J, Zhou F, et al
    beta-Hydroxybutyrate Ameliorates Abeta-Induced Downregulation of TrkA Expression by Inhibiting HDAC1/3 in SH-SY5Y Cells.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317519883496.
    PubMed     Abstract available


  47. KLINE SA, Mega MS
    Stress-Induced Neurodegeneration: The Potential for Coping as Neuroprotective Therapy.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520960873.
    PubMed     Abstract available


  48. LI Y, Yao Z, Yang Y, Zhao F, et al
    A Study on PHF-Tau Network Effected by Apolipoprotein E4.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520971414.
    PubMed     Abstract available


  49. HE M, Stevenson JM, Zhang Y, Hernandez I, et al
    Risk Factors for Cardiovascular Events in Patients on Antidementia Medications.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520922380.
    PubMed     Abstract available


  50. WENG X, George DR, Jiang B, Wang L, et al
    Association Between Subjective Cognitive Decline and Social and Emotional Support in US Adults.
    Am J Alzheimers Dis Other Demen. 2020;35:1533317520922392.
    PubMed     Abstract available


    November 2019
  51. KU BD, Kim H, Kim YK, Ryu HU, et al
    Comparison of Urinary Alzheimer-Associated Neural Thread Protein (AD7c-NTP) Levels Between Patients With Amnestic and Nonamnestic Mild Cognitive Impairment.
    Am J Alzheimers Dis Other Demen. 2019 Nov 18:1533317519880369.
    PubMed     Abstract available


    May 2019
  52. FIELDS NL, Xu L, Miller VJ
    Caregiver Burden and Desire for Institutional Placement-The Roles of Positive Aspects of Caregiving and Religious Coping.
    Am J Alzheimers Dis Other Demen. 2019;34:199-207.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: